This National Law Journal piece examines the NLRB decision to include scholarship football players as employees of Northwestern University.

The Supreme Court is set to hear oral argument in October on whether class and collective action waivers are enforceable.

My colleague Tyrone Thomas was quoted in a SHRM article entitled Confront Employees Who Perpetrate Domestic Violence in which he comments on ways employers can investigate an employee’s alleged off-duty, off-site domestic violence.

Over the summer, we posted about an interesting New Jersey appellate court decision (Rodriquez v. Raymours Furniture) enforcing a provision in a job application that reduced the period in which an employee could sue an employer to six months from the date of the adverse employment action.

BlueInGreen was acquired by Chart Industries for an estimated $20 million. BlueInGreen is a water solutions company that provides a method for delivering dissolved oxygen, carbon dioxide and ozone into water.

In the latest edition of Clean-Tech Law Alert published by Clean Edge, Mintz Levin lawyers provide insights on the following topics.

On Thursday, June 23, the New England Women in Energy and Environment is hosting its first annual "Women in Energy and the Environment Shaping the Agenda" Panel Series from 5:30-8:30pm at the MIT Sloan School of Management.

While the potential Iran nuclear deal, the budget, and spending bills dominate Congress’ attention leading up to the Memorial Day recess, committees in both chambers have not forgotten about energy policy...

On March 27, 2025, as expected, the SEC under the Trump administration abandoned the climate disclosure rule promulgated by the Biden administration, specifically stating in a court filing that it would no longer defend the climate disclosure rule.

Bethany Hills, Chair of Mintz Levin's FDA practice explains why the firm's well-established Health Care, Mergers & Acquisitions, and Intellectual Property practices, coupled with the firm's work...

As we predicted in yesterday's post, FDA approved a new biosimilar product, Sandoz's Erelzi (etanercept-szzs), which is a biosimilar to Amgen's Enbrel (etanercept), on August 30th.

Continuing our current coverage of health policy issues and trends, Mintz Levin's Health Law Practice and ML Strategies have issued a joint Alert regarding the Massachusetts Health Policy Commission's Annual Cost Trends Hearings.

The article describes several key aspects of the Overpayment Rule, identifies open questions, and discusses the Overpayment Rule's implications for compliance as well as health care fraud enforcement.

The SEC filed a civil action against against EB5 Asset Manager, LLC and its owner Lin Zhong in the United States District Court of Southern Florida on November 3, 2015.

Last week we wrote about a new business interruption insurance policy that is being rolled out to healthcare providers which will provide specific coverage for various ebola-related losses.

On October 1, 2018, Massachusetts will become the 49th state to adopt a version of the Uniform Trade Secrets Act.

As 2024 begins and intellectual property (IP) strategies are being developed for the new year, it is a good time to reflect on what IP issues were prominent in 2023.

My colleague, Tyrone Thomas, was quoted in The Patriot News article entitled "Does a Settlement of Remaining Penn State Sanctions Issues Help the NCAA"...

There is a glut of information out there regarding privacy and cybersecurity these days. Our new feature "What We're Reading" provides a curated list of articles, blogs, newsletters, and books that you may find interesting and helpful.

There is a glut of information out there regarding privacy and cybersecurity these days. Our new feature "What We're Reading" provides a curated list of articles, blogs, newsletters, and books...